sesamin has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, M; Deng, P; Du, Y; He, G; Wang, C; Yan, X; Yang, G | 1 |
| Erben, U; Freise, C; Kim, KY; Ruehl, M; Seehofer, D; Somasundaram, R; Trowitzsch-Kienast, W; Zeitz, M | 1 |
2 other study(ies) available for sesamin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Checkpoints; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dioxoles; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Interleukin-6; Lignans; Liver Neoplasms; Phytotherapy; Plant Extracts; Seeds; Sesamum; Signal Transduction; STAT3 Transcription Factor; Tumor Suppressor Protein p53 | 2013 |
(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Dioxoles; Humans; Interleukin-6; Lignans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; NF-kappa B; Vascular Endothelial Growth Factor A | 2012 |